IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BRUCATO, ANTONIO LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.744
EU - Europa 17.552
AS - Asia 15.192
SA - Sud America 2.288
AF - Africa 373
OC - Oceania 348
Continente sconosciuto - Info sul continente non disponibili 23
Totale 55.520
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.661
IT - Italia 5.611
SG - Singapore 4.342
CN - Cina 4.031
GB - Regno Unito 2.802
RU - Federazione Russa 1.603
BR - Brasile 1.536
HK - Hong Kong 1.520
DE - Germania 1.443
FR - Francia 1.173
VN - Vietnam 1.038
JP - Giappone 803
SE - Svezia 739
CA - Canada 696
BD - Bangladesh 646
ES - Italia 646
IN - India 642
IE - Irlanda 588
NL - Olanda 515
FI - Finlandia 474
TR - Turchia 425
ID - Indonesia 366
AU - Australia 304
BE - Belgio 284
KR - Corea 279
MX - Messico 257
AR - Argentina 244
CO - Colombia 240
CH - Svizzera 199
DK - Danimarca 187
GR - Grecia 187
PH - Filippine 158
UA - Ucraina 156
PL - Polonia 154
AT - Austria 149
TW - Taiwan 116
PT - Portogallo 111
TH - Thailandia 109
IL - Israele 99
RO - Romania 97
SA - Arabia Saudita 94
CL - Cile 91
PK - Pakistan 82
CZ - Repubblica Ceca 76
IQ - Iraq 74
ZA - Sudafrica 70
CI - Costa d'Avorio 64
MY - Malesia 61
IR - Iran 59
NO - Norvegia 54
PE - Perù 54
EC - Ecuador 49
HU - Ungheria 46
EU - Europa 43
AE - Emirati Arabi Uniti 42
EG - Egitto 42
NZ - Nuova Zelanda 42
RS - Serbia 34
MA - Marocco 31
VE - Venezuela 31
BG - Bulgaria 30
TN - Tunisia 29
DZ - Algeria 28
KE - Kenya 28
SI - Slovenia 28
UZ - Uzbekistan 26
CR - Costa Rica 25
LT - Lituania 25
LU - Lussemburgo 25
JO - Giordania 24
LB - Libano 24
SK - Slovacchia (Repubblica Slovacca) 23
BY - Bielorussia 21
HR - Croazia 21
AL - Albania 20
GT - Guatemala 18
QA - Qatar 17
PY - Paraguay 16
AZ - Azerbaigian 15
NP - Nepal 15
HN - Honduras 14
JM - Giamaica 13
NG - Nigeria 13
UY - Uruguay 13
BO - Bolivia 12
PA - Panama 12
ET - Etiopia 10
GE - Georgia 10
GH - Ghana 10
OM - Oman 10
PR - Porto Rico 9
PS - Palestinian Territory 9
KW - Kuwait 8
SC - Seychelles 8
BB - Barbados 7
DO - Repubblica Dominicana 7
LK - Sri Lanka 7
AO - Angola 6
IS - Islanda 6
SV - El Salvador 6
Totale 55.417
Salva come PNG Salva come JPEG
Città #
Singapore 2.364
Southend 2.125
Ashburn 1.486
Hong Kong 1.225
Milan 1.126
San Jose 1.066
Dallas 1.058
Chandler 1.013
Fairfield 920
Redwood City 683
Council Bluffs 667
Beijing 598
Princeton 580
Dublin 574
Wilmington 544
Seattle 524
Houston 511
Woodbridge 430
Los Angeles 416
Rome 407
New York 393
Helsinki 361
Ann Arbor 330
Lauterbourg 318
Cambridge 317
Frankfurt am Main 297
Ho Chi Minh City 283
Boardman 277
Moscow 273
Hanoi 265
Tokyo 259
Santa Clara 251
Des Moines 238
Guangzhou 236
Buffalo 235
Nanjing 224
Jakarta 218
Bengaluru 217
Hanover 210
Hefei 210
Chicago 201
São Paulo 196
Shanghai 192
Istanbul 168
The Dalles 165
Toronto 163
Columbus 161
Madrid 161
Dearborn 145
Phoenix 145
Central District 141
Naples 130
Seoul 130
London 127
Turin 117
Boston 106
Nuremberg 103
Bologna 101
Florence 99
Cangzhou 93
Paris 92
Changsha 90
Berlin 84
Grafing 84
Jinan 84
Tianjin 80
Munich 79
Brussels 78
Vienna 78
Buenos Aires 77
Hangzhou 76
Amsterdam 73
Athens 73
Shenzhen 72
Taipei 71
Shenyang 70
Bari 69
Redmond 68
Atlanta 67
Cleveland 67
Ottawa 67
San Diego 67
Sydney 67
Bogotá 66
Melbourne 65
Nanchang 65
Abidjan 64
Washington 64
Falls Church 63
Montreal 62
Warsaw 62
Medellín 61
Barcelona 60
Porto Alegre 56
Hebei 53
Jacksonville 53
Chengdu 52
Manchester 50
Ankara 49
Belo Horizonte 49
Totale 29.300
Salva come PNG Salva come JPEG
Nome #
2015 ESC Guidelines for the diagnosis and management of pericardial diseases 2.872
Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence : the AIRTRIP randomized clinical trial 1.799
COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): A multicentre, randomized, double-blind, placebo-controlled trial 1.765
Linee guida ESC 2015 per la diagnosi e il trattamento delle malattie del pericardio : Task Force per la Diagnosi e il Trattamento delle Malattie del Pericardio della Società Europea di Cardiologia (ESC) 1.615
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation : the COPPS-2 randomized clinical trial 1.170
The autoinflammatory side of recurrent pericarditis: enlightening the pathogenesis for a more rational treatment 1.054
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 671
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 667
Colchicine for recurrent pericarditis (CORP): A randomized trial 637
Controversial issues in the management of pericardial diseases 632
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 587
Corticosteroids for Recurrent Pericarditis : High Versus Low Doses: A Nonrandomized Observation 525
Gli antagonisti dell’interleuchina-1: una nuova classe di farmaci per il trattamento della pericardite ricorrente. Una guida pratica per il cardiologo clinico 523
The contemporary role of cardiac computed tomography and cardiac magnetic resonance imaging in the diagnosis and management of pericardial diseases 521
Risk of constrictive pericarditis after acute pericarditis 489
Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) 484
Good prognosis for pericarditis with and without myocardial involvement: Results from a multicenter, prospective cohort study 449
Anti-interleukin-1 agents for pericarditis : a primer for cardiologists 448
A decision-making algorithm proposal for PICCs and midlines insertion in patients with advanced kidney disease: A pilot study 441
Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: Implications for the diagnosis, therapy, and prognosis of pericarditis 433
Colchicine for pericarditis: Hype or hope? 429
Three-month mortality in permanently bedridden medical non-oncologic patients. The BECLAP study (permanently BEdridden, creatinine CLearance, albumin, previous hospital admissions study) 411
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19 : An International, Multicenter Retrospective Meta-analysis 407
Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis 392
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 369
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 349
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 347
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 346
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: A multi-centre all-case analysis 345
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 341
Prevention of congenital heart block in children of SSA-positive mothers 340
Anti-heart and anti-intercalated disk autoantibodies: Evidence for autoimmunity in idiopathic recurrent acute pericarditis 323
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 322
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 288
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 285
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 284
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation : insights from the REPOSI study 282
Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies 281
Snodi decisionali nella gestione clinica della pericardite : statement dell’Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) 281
Dieci quesiti in tema di colchicina come “nuovo” farmaco cardiovascolare 273
Case Report: Pericardial Effusion Treated With Pericardiectomy Plus Right Atrial Mass Resection: A 2-Year Follow-Up of Cardiac Rosai-Dorfman Disease 265
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: ‘Colchicine treatment in community healthcare setting to prevent severe COVID-19’ by Della-Torre et al 261
Management of pericarditis in women 258
Novel Pharmacotherapies for Recurrent Pericarditis : Current Options in 2020 257
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 254
Arrhythmias presenting in neonatal lupus 251
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 251
Anti-inflammatory and immunosuppressive drugs and reproduction 248
Analysis of the characteristics of patients admitted to internal medicine wards for exacerbation of chronic obstructive pulmonary disease, and discharge phase optimization. The SDO-ARCA project of the scientific society FADOI 247
The role of early contrast-enhanced chest computed tomography in the aetiological diagnosis of patients presenting with cardiac tamponade or large pericardial effusion 245
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 245
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 239
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 238
Dieci quesiti in tema di versamento pericardico 228
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 228
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry 227
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards : data from the RePoSI Registry 221
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases 219
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 218
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 211
Prevalence and prognosis of pericardial effusion in patients affected by pectus excavatum : A case-control study 210
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review 209
Correlation between continuous Positive end-expiratory pressure (PEEP) values and occurrence of Pneumothorax and Pneumomediastinum in SARS-CoV2 patients during non-invasive ventilation with Helmet 205
Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease : a case report 200
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 198
Management of acute and recurrent pericarditis in pregnancy 198
Concentration of autoantibodies to native 60‐kd ro/ss‐a and denatured 52‐kd ro/ss‐a in eluates from the heart of a child who died with congenital complete heart block 195
Wytyczne ESC dotyczce rozpoznawania i leczenia chorób osierdzia w 2015 roku 193
Cardiac tamponade 190
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 187
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero 186
Management of Acute and Recurrent Pericarditis : JACC State-of-the-Art Review 186
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block : an Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group" 182
Gender-differences in disease distribution and outcome in hospitalized elderly : Data from the REPOSI study 181
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 180
Passively acquired anti-SSA/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not 179
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards : data from the RePoSI Registry 178
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease 177
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 174
Response to letter regarding article, "good prognosis for pericarditis with and without myocardial involvement : results from a multicenter, prospective cohort study" 174
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 172
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach 166
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 166
Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: Comment on the article by Costedoat-Chalumeau et al 166
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study 165
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy 164
Acute and Recurrent Pericarditis : still Idiopathic? 164
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases 163
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block 163
Recurrent Pericarditis in Children and Adolescents 163
Impact of in utero environment on the offspring of lupus patients 161
Pain management in cryoglobulinaemic syndrome 159
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 159
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus 158
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 157
Unsuspected Active Sarcoidosis Diagnosed by 18F-FDG PET/CT During the Search for a Primary Tumour in a Patient with Bone Lesions 156
Bacterial pericarditis due to providencia stuartii: An atypical case of relapsing pericarditis 156
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 155
Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study 155
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 151
Totale 36.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021763 0 0 0 0 0 0 0 0 0 0 381 382
2021/20225.262 337 349 335 397 507 398 359 399 549 434 399 799
2022/20235.326 754 374 335 529 573 859 197 414 473 182 425 211
2023/20244.880 248 383 310 312 694 520 310 331 216 334 600 622
2024/20258.813 461 784 336 662 641 491 607 962 721 758 919 1.471
2025/202618.679 1.426 1.384 1.909 1.394 1.712 1.500 2.473 1.132 2.312 1.431 2.006 0
Totale 57.864